LGND Scorecard | LIGAND PHARMACEUTICALS INCORPORATED

LIGAND PHARMACEUTICALS INCORPORATED (LGND) Scorecard

2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

57/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 8 wins, 4 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q22/3	WinLGND / S&P 58.32% / 15.20%	WinLGND / S&P 54.89% / 15.00%	LoseLGND / S&P -332.92% / 50.40%
2026-Q12/3	WinLGND / S&P 5.60% / -4.33%	WinLGND / S&P 51.24% / 11.30%	LoseLGND / S&P -203.77% / 27.70%
2025-Q42/3	WinLGND / S&P 6.73% / 2.65%	WinLGND / S&P 60.40% / 9.00%	LoseLGND / S&P -3045.00% / 13.40%
2025-Q32/3	WinLGND / S&P 55.82% / 8.12%	WinLGND / S&P 64.83% / 4.61%	LoseLGND / S&P -19.12% / 13.45%
2025-Q21/3	LoseLGND / S&P 8.12% / 10.94%	WinLGND / S&P 40.54% / 4.83%	LoseLGND / S&P -274.89% / 10.63%
2025-Q12/3	WinLGND / S&P -1.88% / -4.27%	WinLGND / S&P 53.40% / 4.98%	LoseLGND / S&P -234.59% / 10.57%
2024-Q42/3	WinLGND / S&P 7.05% / 2.41%	WinLGND / S&P 27.28% / 5.25%	LoseLGND / S&P -106.90% / 6.15%
2024-Q32/3	WinLGND / S&P 18.79% / 5.89%	LoseLGND / S&P -0.76% / 5.89%	WinLGND / S&P 206.10% / 6.11%
2024-Q22/3	WinLGND / S&P 15.27% / 4.28%	LoseLGND / S&P -25.82% / 5.38%	WinLGND / S&P 61.54% / 5.12%
2024-Q11/3	LoseLGND / S&P 2.35% / 10.56%	LoseLGND / S&P -41.92% / 5.71%	WinLGND / S&P 325.60% / 5.59%
2023-Q41/3	WinLGND / S&P 19.19% / 11.69%	LoseLGND / S&P -33.09% / 6.81%	LoseLGND / S&P -245.73% / 7.78%
2023-Q30/3	LoseLGND / S&P -16.89% / -3.27%	LoseLGND / S&P -15.95% / 7.52%	LoseLGND / S&P -164.57% / -5.03%
2023-Q20/3	LoseLGND / S&P -1.98% / 8.74%	LoseLGND / S&P -4.47% / 9.50%	LoseLGND / S&P -391.84% / -8.57%
2023-Q12/3	WinLGND / S&P 10.12% / 7.50%	LoseLGND / S&P -8.61% / 10.77%	WinLGND / S&P -7.41% / -15.69%
2022-Q41/3	WinLGND / S&P 24.35% / 7.56%	LoseLGND / S&P -18.75% / 11.88%	LoseLGND / S&P -160.12% / -17.99%
2022-Q31/3	WinLGND / S&P -3.49% / -4.88%	LoseLGND / S&P -27.42% / 13.47%	LoseLGND / S&P -131.75% / -1.41%
2022-Q20/3	LoseLGND / S&P -20.69% / -16.10%	LoseLGND / S&P -17.68% / 13.71%	LoseLGND / S&P -117.63% / 11.04%
2022-Q11/3	LoseLGND / S&P -27.17% / -4.60%	WinLGND / S&P 20.13% / 15.97%	LoseLGND / S&P -41.56% / 42.23%
2021-Q41/3	LoseLGND / S&P 10.87% / 11.03%	WinLGND / S&P 47.68% / 15.00%	LoseLGND / S&P -1755.00% / 96.40%
2021-Q33/3	WinLGND / S&P 6.20% / 0.58%	WinLGND / S&P 75.55% / 10.77%	WinLGND / S&P 167575800088204416.00% / 69.42%
2021-Q21/3	LoseLGND / S&P -13.95% / 8.55%	WinLGND / S&P 81.03% / 6.58%	LoseLGND / S&P -812.82% / 51.81%
2021-Q12/3	WinLGND / S&P 53.29% / 6.17%	WinLGND / S&P 68.75% / -1.06%	LoseLGND / S&P -194.29% / 7.39%
2020-Q41/3	LoseLGND / S&P 4.33% / 12.15%	WinLGND / S&P 35.98% / -3.72%	LoseLGND / S&P -100.66% / -33.42%
2020-Q30/3	LoseLGND / S&P -14.78% / 8.93%	LoseLGND / S&P -6.17% / -2.04%	LoseLGND / S&P -100.00% / -27.10%
2020-Q21/3	WinLGND / S&P 53.81% / 20.54%	LoseLGND / S&P -27.25% / -0.46%	LoseLGND / S&P -101.23% / -27.11%
2020-Q10/3	LoseLGND / S&P -30.27% / -19.60%	LoseLGND / S&P -53.95% / 3.47%	LoseLGND / S&P -106.91% / -14.75%
2019-Q41/3	LoseLGND / S&P 4.77% / 9.07%	LoseLGND / S&P -52.17% / 5.36%	WinLGND / S&P 408.04% / 2.99%
2019-Q31/3	LoseLGND / S&P -12.80% / 1.70%	LoseLGND / S&P -36.92% / 5.02%	WinLGND / S&P 284.68% / 0.21%
2019-Q21/3	LoseLGND / S&P -9.20% / 4.30%	LoseLGND / S&P -24.48% / 6.64%	WinLGND / S&P 551.54% / 8.65%
2019-Q12/3	LoseLGND / S&P -7.36% / 13.65%	WinLGND / S&P 42.14% / 8.12%	WinLGND / S&P 1557.01% / 14.29%
2018-Q42/3	LoseLGND / S&P -50.56% / -13.52%	WinLGND / S&P 78.21% / 9.05%	WinLGND / S&P 1026.42% / 18.23%
2018-Q33/3	WinLGND / S&P 32.50% / 7.71%	WinLGND / S&P 88.11% / 10.21%	WinLGND / S&P 959.42% / 19.06%
2018-Q23/3	WinLGND / S&P 25.44% / 3.43%	WinLGND / S&P 96.50% / 9.03%	WinLGND / S&P 1181.58% / 14.46%
2018-Q12/3	WinLGND / S&P 20.62% / -0.76%	WinLGND / S&P 54.70% / 7.68%	LoseLGND / S&P -1288.89% / 12.46%
2017-Q41/3	LoseLGND / S&P 0.57% / 6.64%	WinLGND / S&P 29.48% / 7.03%	LoseLGND / S&P -630.00% / 13.82%
2017-Q33/3	WinLGND / S&P 12.15% / 4.48%	WinLGND / S&P 40.06% / 5.68%	WinLGND / S&P 130.00% / 17.57%
2017-Q22/3	WinLGND / S&P 14.70% / 3.09%	WinLGND / S&P 32.94% / 4.83%	LoseLGND / S&P -96.01% / 17.74%
2017-Q11/3	LoseLGND / S&P 4.16% / 6.07%	WinLGND / S&P 24.88% / 3.67%	LoseLGND / S&P -101.65% / 13.32%
2016-Q41/3	LoseLGND / S&P -0.44% / 3.82%	WinLGND / S&P 51.54% / 2.09%	LoseLGND / S&P -100.94% / 7.05%
2016-Q31/3	LoseLGND / S&P -14.43% / 3.85%	WinLGND / S&P 24.77% / 0.20%	LoseLGND / S&P -97.21% / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	LGND total return	S&P 500 Total Return Index
Total return	75.94%	20.78%
Annualized return	75.94%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	LGND total return	S&P 500 Total Return Index
Total return	226.38%	83.14%
Annualized return	26.69%	12.86%

10Y · 2016-09-01 to 2026-08-27

Metric	LGND total return	S&P 500 Total Return Index
Total return	326.09%	319.30%
Annualized return	15.60%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.